To investigate the impact of FAO on the development of pancreatic cancer, we compared the expression of CPT1A, a key marker of FAO, by performing immunohistochemical analysis of tissues from patients with pancreatic cancer (Figure 1A and Figure S1A). Here, CPT1A is linked to pancreatic neoplasm.